Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Previous reports indicated that in-hospital famotidine ...

Engineers at MIT and Caltech have demonstrated an ingestible sensor whose location can be monitored as it moves through the digestive tract, an advance that could help doctors more easily diagnose ...

The aim of the wireless capsule procedure is to measure gastrointestinal (GI) motility (that is, gastric emptying time, small bowel transit time or colonic transit time) by assessing temperature, ...

The Neuro-Gastroenterology and Pediatric Motility Center is a nationally recognized institution, one of the few in the country that is dedicated to diagnosing and treating motility disorders and neuro ...